Insiders · QLGN

QLGN insider transactions

Qualigen Therapeutics Inc. (QLGN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for QLGN

• 526d
  SEC Form 3 filed by new insider Bensler Graydon

  3 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 555d
  SEC Form 3 filed by new insider Braeden Lichti

  3 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 625d
  SEC Form 3 filed by new insider Lim Robert Bradley

  3 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 625d
  SEC Form 3 filed by new insider Becher Campbell

  3 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 640d
  SEC Form 3 filed by new insider Price Cody

  3 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Abdul-Ahad Wajdi

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Poirier Michael S.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Emery Sidney W Jr

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Lotz Christopher L.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by David Richard A.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Kruger Kurt H

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Ritter Ira E.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Arshad Tariq

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Sinha Shishir K.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Korenberg Matthew E

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1360d
  SEC Form 4 filed by Broidrick Amy S.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1403d
  SEC Form 4: Poirier Michael S. bought $17,100 worth of shares (30,000 units at $0.57), increasing direct ownership by 18% to 199,202 units

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1410d
  SEC Form 4: Broidrick Amy S. bought $18,600 worth of shares (30,000 units at $0.62), increasing direct ownership by 667% to 34,500 units

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1598d
  SEC Form 4 filed by Arshad Tariq

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1598d
  SEC Form 4 filed by Broidrick Amy S.

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1710d
  SEC Form 4: Kruger Kurt H bought $9,800 worth of Common Stock (8,000 units at $1.23), increasing direct ownership by 80% to 18,000 units

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1804d
  SEC Form 4 filed by ARSHAD TARIQ

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1804d
  SEC Form 3 filed by ARSHAD TARIQ

  3 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1825d
  SEC Form 4: BROIDRICK AMY S. bought $9,135 worth of Common Stock (4,500 units at $2.03)

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1831d
  SEC Form 4: Poirier Michael S. bought $19,809 worth of Common Stock (11,005 units at $1.80)

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)
• 1833d
  SEC Form 4: Lotz Christopher L. bought $5,022 worth of Common Stock (2,700 units at $1.86), increasing direct ownership by 27% to 12,541 units

  4 - Qualigen Therapeutics, Inc. (0001460702) (Issuer)